DIFFERENTIAL REGULATION OF MDR GENES IN RESPONSE TO 2-ACETYLAMINOFLUORENE TREATMENT IN CULTURED RAT AND HUMAN HEPATOCYTES

Citation
V. Lecureur et al., DIFFERENTIAL REGULATION OF MDR GENES IN RESPONSE TO 2-ACETYLAMINOFLUORENE TREATMENT IN CULTURED RAT AND HUMAN HEPATOCYTES, Carcinogenesis, 17(5), 1996, pp. 1157-1160
Citations number
32
Categorie Soggetti
Oncology
Journal title
ISSN journal
01433334
Volume
17
Issue
5
Year of publication
1996
Pages
1157 - 1160
Database
ISI
SICI code
0143-3334(1996)17:5<1157:DROMGI>2.0.ZU;2-S
Abstract
Expression of P-glycoprotein (P-gp), the mdr gene product, was investi gated in primary cultures of rat and human hepatocytes exposed to 2-ac etylaminofluorene (2-AAF), Increased levels of mdr1 mRNAs were evident in 2-AAF-treated rat hepatocytes by Northern blot analysis using rat mdr gene-specific probes, while transcripts of the mdr2 and mdr3 genes mere decreased and unaffected respectively, Rat hepatocytes exposed t o 2-AAF were also found to accumulate doxorubicin, an anticancer drug known to be transported by P-gp, poorly, thereby demonstrating that 2- AAF-mediated mdr1 induction resulted in increased P-gp activity, In co ntrast to their rat counterparts, human hepatocytes obtained from 10 i ndividuals exhibited no change in both MDR1 and MDR2 mRNA levels, as w ell as in doxorubicin intracellular retention, in response to 2-AAF tr eatment, while cytochromes P-450 CYP1A1 and CYP1A2 were induced in bot h human and rat hepatocyte cultures, These data provide strong evidenc e that regulation of expression of mdr genes in liver cells in respons e to carcinogens such as 2-AAF is gene- and species-specific.